Takeda Pharmaceuticals
Publisher DNA
What defines Takeda Pharmaceuticals?
AI intelligence is not yet available for Takeda Pharmaceuticals. The portfolio data below is up to date.
Portfolio
What does Takeda Pharmaceuticals ship?
Apps
5 apps analysed
Donating plasma just got easier with the BioLife Plasma Services mobile app.
Buddy Bonus referral mechanism lowers acquisition costs
- The appointment scheduling and reminder system provides a convenient way for donors to manage their visits
- The latest update causes immediate crashes on launch, preventing users from accessing accounts or scheduling appointments
Analysis in progress
Analysis in progress
Analysis in progress
Analysis in progress
Single-market publisher, every app ships only to United States.
Based on 2 of 5 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States2 / 2
Core markets (2/2 apps)
User Sentiment
How do users feel about their apps?
0
Positive apps
0
Neutral / mixed
1
Negative apps
15/100
Avg sentiment score
Rivals
Who does Takeda Pharmaceuticals compete with?
The rivals identified
Nemeses(1)
Both applications serve the same donor base within the US medical category, competing directly for appointment scheduling and donor management utility.
Contenders(7)
Both applications serve plasma donors within specific pharmaceutical networks, competing for user retention through appointment scheduling and compensation tracking.
Both applications target plasma donors seeking to manage appointments and track compensation, creating direct competition for user retention and donation activity.
Both applications serve the same donor demographic by providing appointment scheduling and reward management for plasma donation centers.
Both applications serve the same donor demographic by providing tools for appointment scheduling, compensation tracking, and loyalty program management within the plasma donation sector.
Both applications serve the same donor demographic by providing appointment scheduling and compensation tracking within the plasma donation industry.
Both apps serve the same donor demographic by providing digital tools for appointment scheduling and compensation management within their respective plasma collection networks.
Both applications serve the same plasma donor demographic by providing appointment scheduling and compensation tracking tools within the medical utility category.
Same space(6)
This app serves as a broad-spectrum donation management tool for the American Red Cross, offering a wider scope of donation types than the plasma-specific BioLife platform.
This platform acts as a directory for plasma matching, contrasting with the BioLife corporate-managed donation model by focusing on direct donor-to-patient connections.
This regional utility targets a similar donor base but operates as a nonprofit, highlighting the gap in automated screening tools present in the BioLife experience.
It occupies the adjacent medical management space by providing a digital interface for lab appointments and health records, overlapping with the clinical nature of plasma donation.
This app provides a localized donor management interface for New Zealand, serving as a geographic alternative for users outside the Takeda network.
It offers a similar appointment scheduling interface for plasma and blood donors, requiring prior online registration to access mobile features.